Profile
Anthony Hollander is the founder of Azellon Ltd., a company founded in 2007.
He holds the title of Director & Chief Scientific Officer at Azellon Ltd.
Dr. Hollander's former job positions include Chairman-Rheumatology & Tissue Engineering at the University of Bristol, Principal at McGill University, and Professor at The University of Sheffield.
Dr. Hollander's education history includes an undergraduate degree from the University of Bath and a doctorate degree from the University of Bristol.
Anthony Hollander active positions
Companies | Position | Start |
---|---|---|
Azellon Ltd.
Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Founder | 2010-05-31 |
Former positions of Anthony Hollander
Companies | Position | End |
---|---|---|
The University of Sheffield | Corporate Officer/Principal | - |
University of Bristol | Chairman | - |
McGill University | Corporate Officer/Principal | - |
Training of Anthony Hollander
University of Bath | Undergraduate Degree |
University of Bristol | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Azellon Ltd.
Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Anthony Hollander